30% off. Use code SUMMER30 at checkout for 30% off for 12 months on Pro and Premium subscriptions. Subscribe now

Brown Ryan Edward

Track

Insider profile

Performance

Overall performance
1.4
Performance over holding periods
1.4
30 days 90 days 120 days
Average return -2% 8.2% 15.1%
Success rate 0% 68% 82%
Transactions
1 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Brown Ryan Edward's trades of Sarepta Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2024-06-25 2024-06-25
PrS Proposed sale
93,714
345.65
US$2,759,924 		93,714 345.65 US$2,759,924
2024-06-25 2024-06-25
PlS Planned sale
40,959 +42.1%
110.40
US$4,634,532 		40,959 +42.1% 110.40 US$4,634,532
2024-06-25 2024-06-25
PlS Planned sale
13,420 +6.8%
386.48
US$3,347,605 		13,420 +6.8% 386.48 US$3,347,605
2024-06-25 2024-06-25
PlS Planned sale
17,581 -42.8%
162.65
US$2,859,550 		17,581 -42.8% 162.65 US$2,859,550
2024-06-25 2024-06-25
PlS Planned sale
4,168 -9.2%
161.82
US$674,466 		4,168 -9.2% 161.82 US$674,466
2024-06-25 2024-06-25
PlS Planned sale
975 -2.1%
160.31
US$156,302 		975 -2.1% 160.31 US$156,302
2024-06-25 2024-06-25
PlS Planned sale
2,200 -4.5%
159.14
US$350,108 		2,200 -4.5% 159.14 US$350,108
2024-06-25 2024-06-25
PlS Planned sale
7,644 -13.6%
158.07
US$1,208,287 		7,644 -13.6% 158.07 US$1,208,287
2024-03-05 2024-03-01
S Sale
2,000 -5.9%
125.34
US$250,680 		2,000 -5.9% 125.34 US$250,680
2024-03-01 2024-03-01
PrS Proposed sale
2,269
125.44
US$284,635 		2,269 125.44 US$284,635